123 related articles for article (PubMed ID: 25271706)
1. IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis.
Kasperkiewicz M; Süfke S; Schmidt E; Zillikens D
JAMA Dermatol; 2014 Dec; 150(12):1350-1. PubMed ID: 25271706
[No Abstract] [Full Text] [Related]
2. Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study.
Kasperkiewicz M; Schmidt E; Frambach Y; Rose C; Meier M; Nitschke M; Falk TM; Reich K; Ludwig RJ; Zillikens D
J Allergy Clin Immunol; 2011 Jan; 127(1):267-70, 270.e1-6. PubMed ID: 20970174
[No Abstract] [Full Text] [Related]
3. Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis.
Daeschlein G; Scholz S; Lutze S; Eming R; Arnold A; Haase H; Hertl M; Jünger M
Ther Apher Dial; 2015 Jun; 19(3):279-87. PubMed ID: 25511754
[TBL] [Abstract][Full Text] [Related]
4. IgE-specific immunoadsorption: New treatment option for severe refractory atopic dermatitis.
Wegner J; Saloga J; Grabbe S; Wilden S; Vewinger N; Lutz J; Weinmann-Menke J; von Stebut E
Allergy; 2019 Jun; 74(6):1190-1193. PubMed ID: 30636038
[No Abstract] [Full Text] [Related]
5. Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab.
Zink A; Gensbaur A; Zirbs M; Seifert F; Suarez IL; Mourantchanian V; Weidinger S; Mempel M; Ring J; Ollert M
Acta Derm Venereol; 2016 Jan; 96(1):72-6. PubMed ID: 26059424
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption for treatment of severe atopic dermatitis.
Wegner J; Weinmann-Menke J; von Stebut E
Atheroscler Suppl; 2017 Nov; 30():264-270. PubMed ID: 29096848
[TBL] [Abstract][Full Text] [Related]
7. Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis.
Reich K; Deinzer J; Fiege AK; von Gruben V; Sack AL; Thraen A; Weisenseel P; Breuer K; Jäckle S; Meier M
J Allergy Clin Immunol; 2016 Jun; 137(6):1882-1884.e6. PubMed ID: 26993034
[No Abstract] [Full Text] [Related]
8. Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.
Kim JY; Park JS; Park JC; Kim ME; Nahm DH
Ther Apher Dial; 2013 Dec; 17(6):631-7. PubMed ID: 24330559
[TBL] [Abstract][Full Text] [Related]
9. Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis.
Kasperkiewicz M; Schmidt E; Ludwig RJ; Zillikens D
Front Immunol; 2018; 9():254. PubMed ID: 29520268
[TBL] [Abstract][Full Text] [Related]
10. Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults.
Glatz M; Buchner M; von Bartenwerffer W; Schmid-Grendelmeier P; Worm M; Hedderich J; Fölster-Holst R
Acta Derm Venereol; 2015 Feb; 95(2):191-6. PubMed ID: 24696225
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin E-Selective Immunoadsorption Reduces Peripheral and Skin-Bound Immunoglobulin E and Modulates Cutaneous IL-13 Expression in Severe Atopic Dermatitis.
Reich K; Hartjen A; Reich J; Schröder J; Steingrube N; Bresch M; Ertas B; Falk TM; Blödorn-Schlicht N; Jäckle S; Meier M
J Invest Dermatol; 2019 Mar; 139(3):720-723. PubMed ID: 30365931
[No Abstract] [Full Text] [Related]
12. Does the severity of atopic dermatitis correlate with serum IgE levels?
Joishy M; Alfaham M; Tuthill D
Pediatr Allergy Immunol; 2005 May; 16(3):283. PubMed ID: 15853962
[No Abstract] [Full Text] [Related]
13. Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E.
Quist SR; Ambach A; Göppner D; Quist J; Franke I; Bonnekoh B; Gollnick HP
Acta Derm Venereol; 2013 Mar; 93(2):206-8. PubMed ID: 23042516
[No Abstract] [Full Text] [Related]
14. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
15. Synbiotics could not reduce the scoring of childhood atopic dermatitis (SCORAD): a randomized double blind placebo-controlled trial.
Shafiei A; Moin M; Pourpak Z; Gharagozlou M; Aghamohammadi A; Sajedi V; soheili H; Sotoodeh S; Movahedi M
Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):21-8. PubMed ID: 21358011
[TBL] [Abstract][Full Text] [Related]
16. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score].
Silny W; Czarnecka-Operacz M; Silny P
Wiad Lek; 2005; 58(1-2):47-55. PubMed ID: 15991553
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
Silny W; Czarnecka-Operacz M; Silny P
Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
[TBL] [Abstract][Full Text] [Related]
19. Effects of Intramuscular Injection of Autologous Immunoglobulin on Clinical Severity and Serum IgE Concentration in Patients with Atopic Dermatitis.
Nahm DH; Kim ME; Cho SM
Dermatology; 2015; 231(2):145-51. PubMed ID: 26112673
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcal enterotoxin B induces specific IgG4 and IgE antibody serum levels in atopic dermatitis.
Orfali RL; Sato MN; Santos VG; Titz TO; Brito CA; Duarte AJ; Takaoka R; Aoki V
Int J Dermatol; 2015 Aug; 54(8):898-904. PubMed ID: 25312705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
